These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32651050)

  • 1. Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and
    Piersson AD; Mohamad M; Rajab F; Suppiah S
    Acad Radiol; 2021 Oct; 28(10):1447-1463. PubMed ID: 32651050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Voevodskaya O; Sundgren PC; Strandberg O; Zetterberg H; Minthon L; Blennow K; Wahlund LO; Westman E; Hansson O;
    Neurology; 2016 May; 86(19):1754-61. PubMed ID: 27164711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
    J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
    Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M; Moriya M; Nojo T
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.
    Calderón-Garcidueñas L; Mora-Tiscareño A; Melo-Sánchez G; Rodríguez-Díaz J; Torres-Jardón R; Styner M; Mukherjee PS; Lin W; Jewells V
    J Alzheimers Dis; 2015; 48(4):1065-75. PubMed ID: 26402110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
    Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
    Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
    Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreases in Short Term Memory, IQ, and Altered Brain Metabolic Ratios in Urban Apolipoprotein ε4 Children Exposed to Air Pollution.
    Calderón-Garcidueñas L; Mora-Tiscareño A; Franco-Lira M; Zhu H; Lu Z; Solorio E; Torres-Jardón R; D'Angiulli A
    J Alzheimers Dis; 2015; 45(3):757-70. PubMed ID: 25633678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
    Khomenko YG; Kataeva GV; Bogdan AA; Chernysheva EM; Susin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):51-58. PubMed ID: 30778031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite Profile of Alzheimer's Disease in the Frontal Cortex as Analyzed by HRMAS
    Zhang Y; Liu Z; Ji B; Liu L; Wu S; Liu X; Wang S; Wang L
    Front Aging Neurosci; 2018; 10():424. PubMed ID: 30687076
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.
    Voevodskaya O; Poulakis K; Sundgren P; van Westen D; Palmqvist S; Wahlund LO; Stomrud E; Hansson O; Westman E;
    Neurology; 2019 Jan; 92(5):e395-e405. PubMed ID: 30610093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.